drugset / Trial / NCT01677403

A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis

NCT01677403

Phase 4 Unknown 120 enrolled Shandong University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study to evaluate the efficacy,indications,adverse reactions and resistance of combined administration of nebulized tobramycin compared with systemic administration alone in patients with Bronchiectasis in acute exacerbation of Bronchiectasis.

Timeline

Start
2012-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tobramycin Small molecule 80 mg Inhaled

Indications